This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kakizuka A, Miller Jr WH, Umesono K, Warrell Jr RP, Frankel SR, Murty VV et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663–674.
Redner RL . Variations on a theme: the alternate translocations in APL. Leukemia 2002; 16: 1927–1932.
Mistry AR, Pedersen EW, Solomon E, Grimwade D . The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood Rev 2003; 17: 71–97.
Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581–3588.
Huntly BJ, Bench A, Green AR . Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 2003; 102: 1160–1168.
Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P et al. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 1995; 86: 1540–1547.
Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A et al. Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 2004; 103: 2358–2362.
Gu BW, Xiong H, Zhou Y, Chen B, Wang L, Dong S et al. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. Proc Natl Acad Sci USA 2002; 99: 7640–7645.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Subramaniyam, S., Nandula, S., Nichols, G. et al. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?. Leukemia 20, 2193–2195 (2006). https://doi.org/10.1038/sj.leu.2404406
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404406